As Forestar Group Com (FOR) Market Value Rose, Sg Americas Securities Has Lowered Holding by $793,275; Medicines Co (Put) (MDCO) Shareholder Atika Capital Management Decreased Its Position

January 16, 2018 - By Darrin Black

Sg Americas Securities Llc decreased its stake in Forestar Group Inc Com (FOR) by 68.94% based on its latest 2017Q3 regulatory filing with the SEC. Sg Americas Securities Llc sold 52,885 shares as the company’s stock rose 8.43% with the market. The institutional investor held 23,832 shares of the real estate company at the end of 2017Q3, valued at $375,000, down from 76,717 at the end of the previous reported quarter. Sg Americas Securities Llc who had been investing in Forestar Group Inc Com for a number of months, seems to be less bullish one the $897.49M market cap company. The stock decreased 0.23% or $0.05 during the last trading session, reaching $21.4. About 28,282 shares traded. Forestar Group Inc. (NYSE:FOR) has risen 26.00% since January 16, 2017 and is uptrending. It has outperformed by 9.30% the S&P500.

Brad Farber decreased its stake in Medicines Co (Put) (MDCO) by 45.08% based on its latest 2017Q3 regulatory filing with the SEC. Atika Capital Management Llc sold 90,300 shares as the company’s stock declined 20.30% while stock markets rallied. The hedge fund run by Brad Farber held 110,000 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $4.08M, down from 200,300 at the end of the previous reported quarter. Atika Capital Management Llc who had been investing in Medicines Co (Put) for a number of months, seems to be less bullish one the $1.88B market cap company. The stock decreased 5.09% or $1.4 during the last trading session, reaching $26.11. About 746,452 shares traded. The Medicines Company (NASDAQ:MDCO) has risen 16.70% since January 16, 2017 and is uptrending. It has by 0.00% the S&P500.

Among 10 analysts covering The Medicines Co (NASDAQ:MDCO), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. The Medicines Co had 32 analyst reports since August 28, 2015 according to SRatingsIntel. Cowen & Co maintained it with “Buy” rating and $54.0 target in Tuesday, August 29 report. The rating was maintained by Cowen & Co with “Buy” on Wednesday, August 9. Oppenheimer maintained the shares of MDCO in report on Monday, August 28 with “Hold” rating. The stock has “Buy” rating by H.C. Wainwright on Monday, December 5. The rating was maintained by Cowen & Co on Tuesday, October 10 with “Buy”. Citigroup maintained it with “Neutral” rating and $43 target in Monday, July 17 report. The rating was maintained by Oppenheimer with “Hold” on Wednesday, July 12. On Monday, August 31 the stock rating was maintained by Oppenheimer with “Market Perform”. The stock has “Buy” rating by Jefferies on Monday, June 26. The firm has “Neutral” rating by Citigroup given on Wednesday, July 26.

Since December 7, 2017, it had 1 insider purchase, and 1 sale for $1.60 million activity. ESHELMAN FREDRIC N bought $5.31M worth of The Medicines Company (NASDAQ:MDCO) on Thursday, December 7.

Analysts await The Medicines Company (NASDAQ:MDCO) to report earnings on February, 27. They expect $-1.48 earnings per share, down 14.73% or $0.19 from last year’s $-1.29 per share. After $-0.42 actual earnings per share reported by The Medicines Company for the previous quarter, Wall Street now forecasts 252.38% negative EPS growth.

Atika Capital Management Llc, which manages about $348.10M US Long portfolio, upped its stake in U S Silica Hldgs Inc (NYSE:SLCA) by 10,500 shares to 35,000 shares, valued at $1.09M in 2017Q3, according to the filing. It also increased its holding in Tempur Sealy Intl Inc (NYSE:TPX) by 33,000 shares in the quarter, for a total of 75,000 shares, and has risen its stake in Intuitive Surgical Inc (NASDAQ:ISRG).

Investors sentiment decreased to 0.78 in Q3 2017. Its down 0.44, from 1.22 in 2017Q2. It worsened, as 32 investors sold MDCO shares while 64 reduced holdings. 19 funds opened positions while 56 raised stakes. 85.15 million shares or 1.36% less from 86.33 million shares in 2017Q2 were reported. Cibc Asset Mngmt has 6,296 shares. Wells Fargo And Com Mn holds 123,384 shares. Invesco Limited has 177,018 shares for 0% of their portfolio. Nationwide Fund Advisors stated it has 68,238 shares or 0.01% of all its holdings. Principal Grp Incorporated reported 492,240 shares or 0.02% of all its holdings. 78,000 were reported by Atika Cap Management Ltd Liability. State Board Of Administration Of Florida Retirement Sys owns 39,599 shares for 0% of their portfolio. State Street holds 0.01% of its portfolio in The Medicines Company (NASDAQ:MDCO) for 2.09M shares. Ls Advsrs Limited holds 2,608 shares. Asset Mngmt Inc owns 25,008 shares for 0.02% of their portfolio. Strs Ohio holds 0% in The Medicines Company (NASDAQ:MDCO) or 3,000 shares. Metropolitan Life Insurance Ny holds 0.01% of its portfolio in The Medicines Company (NASDAQ:MDCO) for 46,231 shares. Bb&T Securities owns 30,674 shares for 0.02% of their portfolio. Wellington Gru Inc Limited Liability Partnership has 10.15M shares. Guggenheim Capital Limited Liability reported 123,742 shares stake.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts